Reactive Center Loop Insertion in α-1-Antitrypsin Captured by Accelerated Molecular Dynamics Simulation
- 17 January 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (4) , 634-646
Abstract
Protease inhibition by metastable serine protease inhibitors (serpins) is mediated by one of the largest functional intradomain conformational changes known in biology. In this extensive structural rearrangement, protease–serpin complex formation triggers cleavage of the serpin reactive center loop (RCL), its subsequent insertion into central β-sheet A, and covalent trapping of the target protease. In this study, we present the first detailed accelerated molecular dynamics simulation of the insertion of the fully cleaved RCL in α-1-antitrypsin (α1AT), the archetypal member of the family of human serpins. Our results reveal internal water pathways that allow the initial incorporation of side chains of RCL residues into the protein interior. We observed structural plasticity of the helix F (hF) element that blocks the RCL path in the native state, which is in excellent agreement with previous experimental reports. Furthermore, the simulation suggested a novel role of hF and the connected turn (thFs3A) as chaperones that support the insertion process by reducing the conformational space available to the RCL. Transient electrostatic interactions of RCL residues potentially fine-tune the serpin inhibitory activity. On the basis of our simulation, we generated the α1AT mutants K168E, E346K, and K168E/E346K and analyzed their inhibitory activity along with their intrinsic stability and heat-induced polymerization. Remarkably, the E346K mutation exhibited enhanced inhibitory activity along with an increased rate of premature structural collapse (polymerization), suggesting a significant role of E346 in the gatekeeping of the strain in the metastable native state.Keywords
Funding Information
- Howard Hughes Medical Institute
- Division of Molecular and Cellular Biosciences (MCB1020765)
- Danmarks Grundforskningsfond (DNRF59)
- Novo Nordisk
- Teknologi og Produktion, Det Frie Forskningsråd (FTP 11-105010)
- National Institute of General Medical Sciences (GM31749)
- Innovationsfonden (0603-00439B)
This publication has 80 references indexed in Scilit:
- α-1 antitrypsin deficiency: current and future treatment optionsExpert Opinion on Orphan Drugs, 2014
- Therapeutic Targeting of Misfolding and Conformational Change in α 1 -Antitrypsin DeficiencyFuture Medicinal Chemistry, 2014
- Therapeutic target-site variability in α1-antitrypsin characterized at high resolutionActa Crystallographica Section F Structural Biology and Crystallization Communications, 2011
- Polymers and inflammation: disease mechanisms of the serpinopathiesJournal of Experimental Medicine, 2008
- Probing the local conformational change of α1‐antitrypsinProtein Science, 2007
- Shape-shifting serpins – advantages of a mobile mechanismTrends in Biochemical Sciences, 2006
- Alpha-1-antitrypsin deficiency: diagnosis and treatmentClinics in Liver Disease, 2004
- Serpin Structure, Mechanism, and FunctionChemical Reviews, 2002
- Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into β-sheet AProceedings of the National Academy of Sciences, 1999
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967